Expert Perspectives on Novel Drug Delivery Systems in the Management of Pediatric ADHD
December 20th 2022Jeffrey L. Alvaro, M.D., introduces an upcoming panel discussion surrounding the clinical implications of novel drug delivery systems in the management of Pediatric ADHD, utilizing 3 patient cases.
Drug Holidays and Challenges in Treatment Adherence in Pediatric ADHD
December 13th 2022Robert L. Findling, MD, MBA, and Timothy Wilens, MD, consider the dosing and adherence challenges that arise in pediatric ADHD, as well as the potential benefits and damages of patients taking a break from treatment.